Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Guggenheim Capital LLC

Guggenheim Capital LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 100,276 shares of the medical equipment provider’s stock after buying an additional 2,739 shares during the period. Guggenheim Capital LLC’s holdings in Intuitive Surgical were worth $52,340,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of ISRG. Bennett Selby Investments LP boosted its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after purchasing an additional 17 shares during the period. Onefund LLC boosted its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock worth $494,000 after buying an additional 18 shares during the period. LVW Advisors LLC grew its stake in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after buying an additional 19 shares during the last quarter. Wesbanco Bank Inc. lifted its position in Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after acquiring an additional 19 shares during the last quarter. Finally, Journey Strategic Wealth LLC boosted its holdings in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after acquiring an additional 19 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 0.7 %

NASDAQ ISRG opened at $490.13 on Tuesday. The firm has a market cap of $174.57 billion, a price-to-earnings ratio of 76.46, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a 50 day moving average of $530.71 and a 200-day moving average of $532.76.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the firm’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the completion of the sale, the vice president now owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last three months. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the company. Robert W. Baird dropped their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Citigroup upped their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Truist Financial lowered their price objective on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. CICC Research assumed coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Finally, Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.